Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Athena Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated has a strategic collaboration with hc1; and strategic relationships with Clinical Genomics Pty Ltd and Anthem Inc. The company was founded in 1967 and is headquartered in Secaucus, New Jersey. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
GUINAN MARK | Executive Vice President & CFO | Dec 24 | Option Exercise | 66.51 | 81,756 | 5,437,592 | 155,335 | Dec 28 04:27 PM | GUINAN MARK | Executive Vice President & CFO | Dec 24 | Sale | 120.37 | 81,756 | 9,840,673 | 73,579 | Dec 28 04:27 PM | WILENSKY GAIL R | Director | Nov 24 | Option Exercise | 57.67 | 6,111 | 352,391 | 22,593 | Nov 27 04:38 PM | WILENSKY GAIL R | Director | Nov 24 | Sale | 126.02 | 6,111 | 770,120 | 16,482 | Nov 27 04:38 PM | STANZIONE DANIEL | Director | Nov 23 | Sale | 126.30 | 11,223 | 1,417,459 | 28,349 | Nov 24 04:31 PM | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Oct 21 | Option Exercise | 57.25 | 10,450 | 598,244 | 35,485 | Oct 23 04:42 PM | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Oct 21 | Sale | 125.00 | 10,450 | 1,306,250 | 25,090 | Oct 23 04:42 PM | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Oct 16 | Option Exercise | 66.51 | 291,997 | 19,420,720 | 529,744 | Oct 19 04:17 PM | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Oct 16 | Sale | 120.00 | 291,997 | 35,039,640 | 237,747 | Oct 19 04:17 PM | PREVOZNIK MICHAEL E | SVP & General Counsel | Oct 14 | Option Exercise | 52.17 | 35,591 | 1,856,605 | 75,678 | Oct 15 04:45 PM | PREVOZNIK MICHAEL E | SVP & General Counsel | Oct 14 | Sale | 119.00 | 35,591 | 4,235,329 | 40,087 | Oct 15 04:45 PM | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sep 02 | Option Exercise | 66.51 | 58,392 | 3,883,652 | 126,803 | Sep 04 04:18 PM | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sep 02 | Sale | 110.60 | 58,392 | 6,458,343 | 68,411 | Sep 04 04:18 PM | RING TIMOTHY M | Director | Jun 08 | Option Exercise | 58.50 | 11,730 | 686,209 | 32,235 | Jun 10 04:31 PM | GUINAN MARK | Executive Vice President & CFO | Jun 08 | Option Exercise | 71.17 | 72,596 | 5,166,657 | 146,175 | Jun 10 04:33 PM | GUINAN MARK | Executive Vice President & CFO | Jun 08 | Sale | 117.23 | 72,596 | 8,510,585 | 73,579 | Jun 10 04:33 PM | RING TIMOTHY M | Director | Jun 08 | Sale | 116.60 | 11,730 | 1,367,718 | 20,505 | Jun 10 04:31 PM | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Apr 27 | Option Exercise | 71.17 | 11,717 | 833,899 | 249,464 | Apr 28 04:45 PM | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Apr 27 | Sale | 112.01 | 11,717 | 1,312,433 | 237,747 | Apr 28 04:45 PM | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Apr 27 | Sale | 111.02 | 5,000 | 555,075 | 22,390 | Apr 28 04:37 PM | Davis J. E. | EVP, General Diagnostics | Mar 16 | Sale | 87.75 | 3,513 | 308,251 | 38,086 | Mar 17 04:37 PM | PREVOZNIK MICHAEL E | SVP & General Counsel | Mar 11 | Sale | 104.25 | 2,175 | 226,744 | 40,087 | Mar 12 05:00 PM | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Mar 11 | Sale | 104.25 | 2,501 | 260,729 | 68,411 | Mar 12 04:57 PM | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Mar 10 | Option Exercise | 71.17 | 100 | 7,117 | 237,847 | Mar 12 04:55 PM | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Mar 10 | Sale | 112.19 | 100 | 11,219 | 237,747 | Mar 12 04:55 PM | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Mar 06 | Option Exercise | 71.17 | 230,178 | 16,381,768 | 456,738 | Mar 10 04:38 PM | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Mar 06 | Sale | 112.67 | 230,178 | 25,934,978 | 226,560 | Mar 10 04:38 PM | PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 27 | Sale | 109.02 | 690 | 75,224 | 40,087 | Feb 28 05:53 PM | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 27 | Sale | 109.02 | 789 | 86,017 | 68,411 | Feb 28 05:51 PM | Davis J. E. | EVP, General Diagnostics | Feb 27 | Sale | 109.02 | 1,100 | 119,922 | 38,105 | Feb 28 05:50 PM | PREVOZNIK MICHAEL E | SVP & General Counsel | Feb 26 | Sale | 111.09 | 321 | 35,660 | 41,445 | Feb 28 05:53 PM | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 26 | Sale | 111.09 | 368 | 40,881 | 69,977 | Feb 28 05:51 PM | Davis J. E. | EVP, General Diagnostics | Feb 26 | Sale | 111.09 | 510 | 56,656 | 40,392 | Feb 28 05:50 PM | Davis J. E. | EVP, General Diagnostics | Feb 25 | Sale | 112.73 | 598 | 67,413 | 41,454 | Feb 26 04:34 PM | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Feb 25 | Sale | 112.73 | 405 | 45,656 | 70,701 | Feb 26 04:31 PM |
|